(Q51193218)

English

Antifungal susceptibility of Aspergillus species isolated from invasive oral infection in neutropenic patients with hematologic malignancies.

scientific article published in February 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10052372

Antifungal susceptibility of Aspergillus species isolated from invasive oral infection in neutropenic patients with hematologic malignancies. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10052372

object named as

Aspergillus

1 reference

based on heuristic

inferred from title

author name string

Myoken Y

1

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10052372

Sugata T

2

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10052372

Myoken Y

3

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10052372

Kyo T

4

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10052372

Fujihara M

5

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10052372

Mikami Y

6

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10052372

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 1999

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10052372

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10052372

87

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10052372

2

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10052372

174-179

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10052372

Candidemia in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970269-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspergillosis. The spectrum of the disease in 98 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970269-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Orofacial fungal infections. Nine pathogens that may invade during chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970269-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Invasive Aspergillus of the head and neck.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970269-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspergillus sinusitis in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970269-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Invasive Aspergillus sinusitis in pediatric bone marrow transplant patients. Evaluation and management

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970269-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970269-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid and highly reproducible method for antifungal susceptibility testing of Aspergillus species.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970269-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970269-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of invasive aspergillosis with itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970269-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Invasive oral aspergillosis in immunocompromised patients with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970269-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathological features of invasive oral aspergillosis in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970269-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro antifungal activity of the new triazole D0870 against Penicillium marneffei compared with that of amphotericin B, fluconazole, itraconazole, miconazole and flucytosine.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970269-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970269-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of in vitro antifungal activity of itraconazole and hydroxy-itraconazole by colorimetric MTT assay

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970269-6

7 January 2021

based on heuristic

inferred from DOI database lookup

An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970269-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970269-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970269-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Azole antifungal agents: emphasis on new triazoles

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2899%2970269-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1079-2104(99)70269-6

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10052372

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/10052372

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51193218&oldid=2161398319"